Cargando…

Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer

Progression of aggressive prostate cancers (PCa) with androgen receptor splice variants or neuroendrocrine features is currently untreatable in the clinic. Therefore novel therapies are urgently required. We conducted RNA-seq using tumors from a unique murine transplant mouse model which spontaneous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kirk, Jason S., Schaarschuch, Kevin, Dalimov, Zafardjan, Lasorsa, Elena, Ku, ShengYu, Ramakrishnan, Swathi, Hu, Qiang, Azabdaftari, Gissou, Wang, Jianmin, Pili, Roberto, Ellis, Leigh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413643/ https://www.ncbi.nlm.nih.gov/pubmed/25605014

Ejemplares similares

Combinatorial antitumor effect of HDACs and the PI3K-Akt-mTOR pathway inhibition in a Pten deficient model of prostate cancer
por: Ellis, Leigh, et al.
Publicado: (2013)

Generation of a syngeneic orthotopic transplant model of prostate cancer metastasis
por: Ellis, Leigh, et al.
Publicado: (2014)

Inhibition of Hsp90 Augments Docetaxel Therapy in Castrate Resistant Prostate Cancer
por: Ku, ShengYu, et al.
Publicado: (2014)

YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage
por: Ciamporcero, Eric, et al.
Publicado: (2015)

Mitochondrial protection impairs BET bromodomain inhibitor-mediated cell death and provides rationale for combination therapeutic strategies
por: Lasorsa, E, et al.
Publicado: (2015)

Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration
por: Zhang, Ao, et al.
Publicado: (2015)

Correction: Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration
por: Zhang, Ao, et al.
Publicado: (2023)

Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer
por: Ramakrishnan, Swathi, et al.
Publicado: (2019)

HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma
por: Ramakrishnan, Swathi, et al.
Publicado: (2016)

Clinicopathologic characterization of intradiverticular carcinoma of urinary bladder - a study of 22 cases from a single cancer center
por: Zhong, Hua, et al.
Publicado: (2014)

Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models
por: Shen, Li, et al.
Publicado: (2012)

Establishment and Characterization of a Highly Tumorigenic African American Prostate Cancer Cell Line, E006AA-hT
por: Koochekpour, Shahriar, et al.
Publicado: (2014)

Aldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activity
por: Gangavarapu, Kalyan J, et al.
Publicado: (2013)

Concurrent HDAC and mTORC1 Inhibition Attenuate Androgen Receptor and Hypoxia Signaling Associated with Alterations in MicroRNA Expression
por: Ellis, Leigh, et al.
Publicado: (2011)

Human Prostate Side Population Cells Demonstrate Stem Cell Properties in Recombination with Urogenital Sinus Mesenchyme
por: Foster, Barbara A., et al.
Publicado: (2013)

EZH2 inhibition re-sensitizes multidrug resistant B-cell lymphomas to etoposide mediated apoptosis
por: Smonskey, Matthew, et al.
Publicado: (2016)

Metastatic phenotype in CWR22 prostate cancer xenograft following castration
por: Seedhouse, Steven J., et al.
Publicado: (2015)

Tumor-associated macrophage expression of interferon regulatory Factor-8 (IRF8) is a predictor of progression and patient survival in renal cell carcinoma
por: Muhitch, Jason B., et al.
Publicado: (2019)

Unspecific binding of cRNA probe to plaques in two mouse models for Alzheimer’s disease
por: Schaarschuch, Anne, et al.
Publicado: (2016)

Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies
por: Ellis, Leigh, et al.
Publicado: (2010)

“Disruptive Behavior” or “Expected Benefit” Are Rationales of Seclusion Without Prior Aggression
por: Vruwink, Fleur J., et al.
Publicado: (2022)

Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell Carcinoma
por: Gopalakrishnan, Dharmesh, et al.
Publicado: (2021)

Epigenetic regulation of inflammation in localized aggressive periodontitis
por: Shaddox, L. M., et al.
Publicado: (2017)

Epigenetics, c-Myc and Aggressive B-cell Lymphomas
por: Zhang, Yizhuo, et al.
Publicado: (2012)

Blunt traumatic carotid artery dissection still a pitfall? The rationale for aggressive screening
por: van Wessem, K. J. P., et al.
Publicado: (2010)

Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and Treatments
por: Martinez-Useros, Javier, et al.
Publicado: (2021)

Genomic analysis reveals epigenetic ‘addiction’ underpinning follicular lymphoma and its transformation – a rationale for targeted epigenetic therapies
por: Okosun, Jessica, et al.
Publicado: (2013)

Clinical presentation of posterior cerebral artery occlusions – Clinical rationale for a more aggressive therapeutic strategy?
por: Maus, Volker, et al.
Publicado: (2021)

The epigenetic reprogramming of poorly aggressive melanoma cells by a metastatic microenvironment
por: Seftor, Elisabeth A, et al.
Publicado: (2006)

Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer
por: Sung, Hye Youn, et al.
Publicado: (2017)

Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer?
por: Santos, Pedro Bargão, et al.
Publicado: (2020)

Epigenetically regulated PCDHB15 impairs aggressiveness of metastatic melanoma cells
por: Carrier, Arnaud, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Inhibition of dihydrotestosterone synthesis in prostate cancer by combined frontdoor and backdoor pathway blockade
por: Fiandalo, Michael V., et al.
Publicado: (2018)

The Timing and Predictors of the Early Discontinuation of Breastfeeding in Southwest Iran
por: Hatami, Gissou, et al.
Publicado: (2012)

Life Satisfaction in children and adolescents with beta thalassemia major in southwest Iran
por: Hatami, Gissou, et al.
Publicado: (2014)

Integrating economics into the rationale for multisectoral action on obesity
por: Ellis, Vivian L., et al.
Publicado: (2018)

2,2′-Bis{8-[(benzylamino)methylidene]-1,6-dihydroxy-5-isopropyl-3-methylnaphthalen-7(8H)-one}
por: Hakberdiev, Shukhrat M., et al.
Publicado: (2013)

Genes and Aggressive Behavior: Epigenetic Mechanisms Underlying Individual Susceptibility to Aversive Environments
por: Palumbo, Sara, et al.
Publicado: (2018)

Epigenetic Upregulation of MAGE-A Isoforms Promotes Breast Cancer Cell Aggressiveness
por: Oh, Chaeun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9a9c2teugmobalo6p35om0bujv